Exact Mass: 457.1795316
Exact Mass Matches: 457.1795316
Found 169 metabolites which its exact mass value is equals to given mass value 457.1795316
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Minocycline
C23H27N3O7 (457.18489120000004)
Minocycline is only found in individuals that have used or taken this drug. It is a tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. [PubChem]Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3205 KEIO_ID M159; [MS3] KO009052 KEIO_ID M159; [MS2] KO009051 KEIO_ID M159
5,10-Methylene-THF
5,10-Methylene-THF is an intermediate in glycine, serine and threonine metabolism and one carbon metabolism. 5,10-CH2-THF can also be used as a coenzyme in the biosynthesis of thymidine. More specifically it is the C1-donor in the reactions catalyzed by thymidylate synthase and thymidylate synthase (FAD). It also acts as a coenzyme in the synthesis of serine from glycine via the enzyme serine hydroxymethyl transferase. 5,10-Methylene-THF is a substrate for Methylenetetrahydrofolate reductase. This enzyme converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This reaction is required for the multistep process that converts the amino acid homocysteine to methionine. The body uses methionine to make proteins and other important compounds. 5,10-CH2-THF is a substrate for many enzymes including Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), Aminomethyltransferase (mitochondrial), Serine hydroxymethyltransferase (mitochondrial), Methylenetetrahydrofolate reductase, C-1-tetrahydrofolate synthase (cytoplasmic), Serine hydroxymethyltransferase (cytosolic) and Thymidylate synthase. 5,10-Methylene-THF is an intermediate in the metabolism of Methane and the metabolism of Nitrogen. It is a substrate for Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), Aminomethyltransferase (mitochondrial), Serine hydroxymethyltransferase (mitochondrial), Methylenetetrahydrofolate reductase, C-1-tetrahydrofolate synthase (cytoplasmic), Serine hydroxymethyltransferase (cytosolic) and Thymidylate synthase. [HMDB] COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
AZIMILIDE
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
OA-6129 A
C20H31N3O7S (457.18826160000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3-O-Acetylpapaveroxine
C24H27NO8 (457.17365820000003)
A benzylisoquinoline alkaloid that is 3-O-acetyl-4-O-demethylpapaveroxine in which the phenolic hydroxy group has been converted to the corresponding methyl ether. An intermediate in the biosynthesis of noscarpine in the opium poppy, Papaver somniferum.
5-Methyldihydrofolic acid
5-Methyldihydrofolic acid is a biopterin derivative present in human body fluids and tissues. (PMID: 932231) [HMDB] 5-Methyldihydrofolic acid is a biopterin derivative present in human body fluids and tissues. (PMID: 932231).
(6R)-5,10-Methylenetetrahydrofolate
Azimilide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(4S,4As,5aR,12aS)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
C23H27N3O7 (457.18489120000004)
Etrasimod
C26H26F3NO3 (457.18646820000004)
2-[[4-[(2-Amino-1-methyl-4-oxo-2,3-dihydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
2-[[4-[(2-Amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-methylidenepentanedioic acid
Triazoledione
1-[[5-(4-Chlorophenyl)furan-2-yl]methylideneamino]-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]imidazol-2-one
N-Ac-11-[(2-Amino-2-carboxyethyl)thio]-12-hydroxy-5,7,9-hexadecatrienedioic acid
phenyl(1,2,9,10-tetramethoxy-6-methyl-5,6-dihydro-4H-dibenzo[de,g]quinolin-7-yl)methanone
C28H27NO5 (457.18891320000006)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.432 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.437
Minocycline
C23H27N3O7 (457.18489120000004)
A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ala Cys His Gln
Ala Cys Gln His
Ala His Cys Gln
Ala His Gln Cys
Ala Gln Cys His
Ala Gln His Cys
Cys Ala His Gln
Cys Ala Gln His
Cys His Ala Gln
Cys His Gln Ala
Cys Gln Ala His
Cys Gln His Ala
Gly His Met Asn
Gly His Asn Met
1,2,4-Triazolidine-3,5-dione, 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-4-(2-phenoxyethyl)-
Gly Met His Asn
Gly Met Asn His
Gly Asn His Met
Gly Asn Met His
His Ala Cys Gln
His Ala Gln Cys
His Cys Ala Gln
His Cys Gln Ala
His Gly Met Asn
His Gly Asn Met
His Met Gly Asn
His Met Asn Gly
His Asn Gly Met
His Asn Met Gly
His Gln Ala Cys
His Gln Cys Ala
Met Gly His Asn
Met Gly Asn His
Met His Gly Asn
Met His Asn Gly
Met Asn Gly His
Met Asn His Gly
Asn Gly His Met
Asn Gly Met His
Asn His Gly Met
Asn His Met Gly
Asn Met Gly His
Asn Met His Gly
Gln Ala Cys His
Gln Ala His Cys
Gln Cys Ala His
Gln Cys His Ala
Gln His Ala Cys
Gln His Cys Ala
5-Methyldihydrofolic acid
A member of the class of dihydrofolic acids that is dihydrofolic acid carrying a methyl substituent at position 5.
16-carboxy-17,18,19,20-tetranor-N-acetyl-LTE3
azd-8186
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-6-methyl-N-(3-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
[R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol
C29H28ClNO2 (457.18084580000004)
2-amino-2-ethylpropane-1,3-diol,(4-nitrophenyl) dihydrogen phosphate
C16H32N3O10P (457.18252220000005)
[(S)-(E)]-2-[3-[3-[2-(7-chloro-2-quinolinyl)-ethenyl]-phenyl]-3-hydroxy propyl]-phenyl]-2-Propanol
C29H28ClNO2 (457.18084580000004)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Tematropium metilsulfate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
(6R)-5,10-Methylenetetrahydrofolate
C2140 - Adjuvant > C2078 - Folic Acid Derivative
1,2-DI-N-Pentanoyl-SN-glycero-3-dithiophosphocholine
C18H36NO6PS2 (457.17215660000005)
[(3R,4R,6R)-2,3-dihydroxy-2-methyl-6-(12-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)oxan-4-yl]azanium
1-[[5-(4-Chlorophenyl)furan-2-yl]methylideneamino]-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]imidazol-2-one
5,10-Methylenetetrahydrofolic acid
C2140 - Adjuvant > C2078 - Folic Acid Derivative
Syncarpamide
C28H27NO5 (457.18891320000006)
An alkaloid that is the di-O-cinnamoyl derivative of 3,4-di-O-methylnorepinephrine. Isolated from Zanthoxylum syncarpum, it exhibits antiplasmodial activity.
2-[4-(2,2-Dimethyl-4-oxo-1,3,5,6-tetrahydrobenzo[a]phenanthridin-5-yl)-2-methoxyphenoxy]acetic acid
C28H27NO5 (457.18891320000006)
(1S,4aS,11aR,12aS)-3-carbamoyl-10-(dimethylamino)-1-(dimethylazaniumyl)-4a,5,7-trihydroxy-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracen-2-olate
C23H27N3O7 (457.18489120000004)
ethyl 4-[[2-[4-(2-chlorophenyl)-2-oxo-6,7-dihydro-5H-cyclopenta[b]pyridin-1-yl]acetyl]amino]piperidine-1-carboxylate
C24H28ClN3O4 (457.1768238000001)
4-Morpholinecarboxylic acid [4-[6-amino-5-cyano-3-(4-methylphenyl)-2,4-dihydropyrano[2,3-c]pyrazol-4-yl]phenyl] ester
C25H23N5O4 (457.17499580000003)
4-[[[4-[(4-Fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazin-6-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester
2,4-dihydroxy-3-({3-[(1S,4aS,5R,6R,7S,9S,9aR)-5-hydroxy-1,6-dimethyl-2-oxo-1,2,5,6,7,8,9,9a-octahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)benzoic acid
C24H27NO8 (457.17365820000003)
(4R,12aR)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
C23H27N3O7 (457.18489120000004)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]urea
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
8-(6-aminohexylamino)-2-O-methyl 3,5-cyclic AMP
C17H28N7O6P (457.18385980000005)
(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[(5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaen-17-yl)oxy]oxane-2-carboxylic acid
C23H27N3O7 (457.18489120000004)
Antibiotic OA 6129A
C20H31N3O7S (457.18826160000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
minocycline zwitterion
C23H27N3O7 (457.18489120000004)
A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of minocycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
(6R)-5,10-Methylenetetrahydrofolic acid
The (6R)-stereoisomer of 5,10-methylenetetrahydrofolic acid.
platensimycin A1
C24H27NO8 (457.17365820000003)
A polycyclic cage that is the 5-hydroxy derivative of platensimycin. It is isolated from Streptomyces platensis.
5-Methyltetrahydrofolate(2-)
A dicarboxylic acid dianion resulting from the deprotonation of the two carboxy groups of 5-methyltetrahydrofolic acid; major species at pH 7.3.
ethyl 4-[(1-{10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene}ethyl)amino]butanoate
C24H27NO8 (457.17365820000003)
(2s)-2-[(4-{1-hydroxy-3-imino-4h,5h,6h,6ah,7h,9h-imidazo[1,5-f]pteridin-8-yl}phenyl)formamido]pentanedioic acid
(4s,4as,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
C23H27N3O7 (457.18489120000004)
(2s,3s,4r,5r)-3-{[(2s)-2-amino-1-hydroxy-3-(4-methoxyphenyl)propylidene]amino}-5-(6-aminopurin-9-yl)-4-hydroxyoxolane-2-carboxylic acid
5-[(2r,4s,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-4-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
(2s)-2-amino-3-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}butanoic acid
(4s,12as)-4,7-bis(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
C23H27N3O7 (457.18489120000004)
(2s)-2-({4-[(6ar)-1-hydroxy-3-imino-4h,5h,6h,6ah,7h,9h-imidazo[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid
2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,7s,9s,11r)-11-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
n-{1,7-dichloro-2,5-dihydroxy-8-oxobicyclo[3.3.1]non-6-en-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
2-amino-3-methyl-3-[(3,4,5-trihydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)methoxy]butanoic acid
2,4-dihydroxy-3-[(1-hydroxy-3-{12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,7s,9s)-9-(hydroxymethyl)-5-methyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
ethyl 4-({1-[(2r,4e)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene]ethyl}amino)butanoate
C24H27NO8 (457.17365820000003)
5-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-4-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
6-[(acetyloxy)methyl]-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,6r,7s,9r,12r)-12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
n-[2-(3,4-dimethoxyphenyl)-2-[(3-phenylprop-2-enoyl)oxy]ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
(2e,4e,6r)-n-[(1r,2s,3s,5r)-1,7-dichloro-2,5-dihydroxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
2,4-dihydroxy-3-({1-hydroxy-3-[9-(hydroxymethyl)-5-methyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
(5r,5ar,6s,9ar,9br)-6-[(acetyloxy)methyl]-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
C24H27NO8 (457.17365820000003)
(2e)-n-[(2r)-2-(3,4-dimethoxyphenyl)-2-{[(2e)-3-phenylprop-2-enoyl]oxy}ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
n-(6,8-dichloro-4a-hydroxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl)-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
(11r,15r,17r)-5-[(4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-6-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-[(1-hydroxy-3-{10-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,7s,9s,10r)-10-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
(2e)-n-[(2s)-2-(3,4-dimethoxyphenyl)-2-{[(2e)-3-phenylprop-2-enoyl]oxy}ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
(2e,4e,6r)-n-[(3s,4as,8r,8ar)-6,8-dichloro-4a-hydroxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
2,4-dihydroxy-3-[(1-hydroxy-3-{11-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)